Celcuity (CELC) Total Liabilities (2016 - 2025)
Celcuity (CELC) reported Total Liabilities of $366.0 million for Q4 2025, up 182.62% on a YoY basis from $129.5 million in Q4 2024, and up 1.94% quarter-over-quarter from $359.0 million in Q3 2025.
Celcuity (CELC) Total Liabilities (2016 - 2025) Analysis & Trends
Celcuity has reported Total Liabilities for 10 years, with the latest figure at $366.0 million in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities rose 182.62% year-over-year to $366.0 million; the trailing twelve-month figure through Dec 2025 stood at $366.0 million (up 182.62% YoY), and the FY2025 full-year result was $366.0 million, up 182.62% from the prior year.
- Total Liabilities for Q4 2025 stood at $366.0 million, up from $359.0 million in the prior quarter.
- The five-year high for Total Liabilities was $366.0 million in Q4 2025, with the low at $1.2 million in Q1 2021.
- Historically, Total Liabilities has averaged $87.9 million across 5 years, with a median of $46.4 million in 2023.
- Annual changes were most pronounced in 2021 — Total Liabilities soared 1777.75% — and 2025, when it grew 20.16%.
- Celcuity's Total Liabilities stood at $17.2 million in 2021, then soared by 143.81% to $41.9 million in 2022, then grew by 22.72% to $51.5 million in 2023, then jumped by 151.71% to $129.5 million in 2024, then jumped by 182.62% to $366.0 million in 2025.
- The last three Total Liabilities figures came in at $366.0 million (Q4 2025), $359.0 million (Q3 2025), and $139.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 137.56 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 366.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 366.00 Mn |
| Sep 30, 2025 | 359.04 Mn |
| Jun 30, 2025 | 139.22 Mn |
| Mar 31, 2025 | 131.46 Mn |
| Dec 31, 2024 | 129.50 Mn |
| Sep 30, 2024 | 123.33 Mn |
| Jun 30, 2024 | 115.86 Mn |
| Mar 31, 2024 | 54.44 Mn |
| Dec 31, 2023 | 51.45 Mn |
| Sep 30, 2023 | 49.49 Mn |
| Jun 30, 2023 | 43.38 Mn |
| Mar 31, 2023 | 41.65 Mn |
| Dec 31, 2022 | 41.93 Mn |
| Sep 30, 2022 | 21.77 Mn |
| Jun 30, 2022 | 19.16 Mn |
| Mar 31, 2022 | 18.39 Mn |
| Dec 31, 2021 | 17.20 Mn |
| Sep 30, 2021 | 17.36 Mn |
| Jun 30, 2021 | 15.77 Mn |
| Mar 31, 2021 | 1.19 Mn |